Stocks and Investing Stocks and Investing
Tue, April 6, 2021
[ 12:00 AM ] - WOPRAI
Colin Bristow Initiated (ALXO) at Strong Buy and Held Target at $96 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Bryan Keane Maintained (ACN) at Strong Buy with Increased Target to $310 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Robert Lee Downgraded (AB) to Hold and Held Target at $42 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Katy Huberty Maintained (AAPL) at Buy with Decreased Target to $156 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Initiated (ABNB) at Buy and Held Target at $245 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Salveen Richter Downgraded (ACAD) to Hold and Decreased Target to $25 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Chris Howerton Downgraded (ACAD) to Hold and Decreased Target to $21 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Vamil Divan Downgraded (ACAD) to Hold and Held Target at $25 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Sumant Kulkarni Downgraded (ACAD) to Hold and Decreased Target to $26 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Jeffrey Hung Maintained (ACAD) at Buy with Decreased Target to $28 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Ricky Goldwasser Maintained (ACCD) at Buy with Increased Target to $60 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Initiated (SPOT) at Buy and Held Target at $360 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Richard Baldry Maintained (VTSI) at Strong Buy with Increased Target to $10 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
David Williams Upgraded (VSH) to Strong Buy and Held Target at $30 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Shebly Seyrafi Initiated (VRNS) at Buy and Held Target at $65 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (SWK) at Buy with Increased Target to $219 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Edward Lewis Initiated (YUM) at Hold and Held Target at $118 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Kaumil Gajrawala Initiated (YETI) at Buy and Held Target at $85 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
John Staszak Upgraded (WYNN) to Strong Buy and Held Target at $160 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Downgraded (YELP) to Hold and Held Target at $41 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Initiated (UBER) at Buy and Held Target at $74 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (UNP) at Hold with Increased Target to $180 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Initiated (AMZN) at Buy and Held Target at $200 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Michael Sison Maintained (APD) at Buy with Increased Target to $320 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (TT) at Buy with Increased Target to $180 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Initiated (TTD) at Buy and Held Target at $77 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Ravi Shanker Upgraded (UAL) to Hold and Increased Target to $65 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Tobey Sommer Initiated (APEI) at Strong Buy and Held Target at $43 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (TFII) at Buy with Increased Target to $100 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (AVIR) at Buy with Increased Target to $82 on, Apr 6th, 2021

Matthew Harrison Maintained (AVIR) at Buy with Increased Target to $82 on, Apr 6th, 2021


Published on 2024-10-27 16:07:23 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Buy with Increased Target from $49 to $82 on, Apr 6th, 2021.

Matthew has made no other calls on AVIR in the last 4 months.



There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew

  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $66 on, Friday, January 29th, 2021
Contributing Sources